DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer

Information source: Chonbuk National University Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Normal Volunteers

Intervention: risperidone (Drug); aripiprazole (Drug); haloperidol (Drug); amisulpride (Drug); lactose (Drug)

Phase: N/A

Status: Completed

Sponsored by: Chonbuk National University Hospital

Summary

The aim of the study is to investigate the negative symptoms and cognitive function after administration of antipsychotics in healthy volunteer.

Clinical Details

Official title: Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer: a Double-blind, Randomized Trial of a Single Dose of Placebo, Haloperidol, Amisulpride, Risperidone and Aripiprazole

Study design: Time Perspective: Prospective

Primary outcome:

Symptoms assessment by objective and subjective rating scale

Symptoms assessment by objective and subjective rating scales & CNT

Symptoms assessment by objective and subjective rating scales

Secondary outcome:

Symptoms assessment by objective rating scale

Symptoms assessment by objective rating scale

Eligibility

Minimum age: 18 Years. Maximum age: 38 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Aged 18-38 years and meet no DSM-IV diagnostic criteria as assessed by using the

Structured Clinical Interview for DSM-IV, research version. Exclusion Criteria:

- 1) anyone who participated in other clinical trials within 30 days from the start of

this clinical trial or is currently participating in one,

- 2) anyone who has progressive disease or in unstable medical condition unfit for the

trial,

- 3) anyone who has been diagnosed in psychiatric terms in the past, depends on

psychotropic substance, or has overdosed or depended on the substance or alcohol (except for coffee or tobacco) within 1 month from the trial start,

- 4) anyone who is suicidal or highly probable of suicides, or

- 5) anyone who has test results considered clinically meaningful

Locations and Contacts

Chonbuk national university hospital, Jeonju, Korea, Republic of
Additional Information

Starting date: March 2009
Last updated: August 19, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017